- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Hitachi Medical warns of first-half loss
Hitachi Medical expects to report a net loss of $5.67 million for the half-year ended Sept. 30. The company said that despite strong U.S. sales of MRI and diagnostic ultrasound systems, CT and ultrasound sales in Japan have been weak. Hitachi had
Hitachi Medical expects to report a net loss of $5.67 million for the half-year ended Sept. 30. The company said that despite strong U.S. sales of MRI and diagnostic ultrasound systems, CT and ultrasound sales in Japan have been weak.
Hitachi had projected a profit of $3.02 million for the period. The firm said group sales would likely reach $451 million, some $54.44 million short of the original projection.
A spokesperson for the Hitachi Medical Corporation of America said the ultrasound division in the U.S. had exceeded its sales goals in the past few months. She said the company plans new product introductions at the RSNA show.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
